Biogen Idec’s ELOCTATE and ALPROLIX Will Grow the Hemophilia Market, a ZoomRx 

Biogen Idec’s ELOCTATE and ALPROLIX Will Grow the Hemophilia Market, a ZoomRx Study Finds
Business Wire
 
View Comments